Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Real-world application of targeted next-generation sequencing for identifying molecular variants in Asian non-small-cell lung cancer

Fig. 4

Genomic landscape of CNVs and gene fusions in NSCLC patients. A Oncoprint diagram showing the distribution of copy number variations (CNVs) in the NSCLC patient cohort. The X-axis represents individual patient samples, while the Y-axis lists the affected genes. Red indicates gene amplifications, and gray denotes no alterations. B Distribution of gene fusions in the NSCLC patient cohort. The X-axis represents individual patient samples, and the Y-axis shows the fusion variants. Purple represents structural variants, pink denotes exon skipping, and gray indicates no alterations

Back to article page